Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03042442 |
Date of registration:
|
24/01/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers Substudy
CDNPAN |
Scientific title:
|
Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers Substudy |
Date of first enrolment:
|
January 1, 2017 |
Target sample size:
|
114 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03042442 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Romania
| | | | | | | |
Contacts
|
Name:
|
Livia Petrusel, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Iuliu Hatieganu University of Medicine |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Age over 18 years old
2. EUS or surgery biopsy confirming the diagnosis of adenocarcinoma
3. Informed consent
Exclusion Criteria:
1. obvious malabsorption
2. artificial nutrition
3. hyperthyroidism
4. major depression
5. other causes of malnutrition
6. refusing to enter the study
Age minimum:
18 Years
Age maximum:
100 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Pain
|
Pancreatic Cancer, Adult
|
Diabetes Mellitus
|
Cachexia
|
Intervention(s)
|
Other: Follow-up
|
Other: Clinical, venous blood samples, pancreatic tissue
|
Diagnostic Test: Point-of care biomarkers
|
Primary Outcome(s)
|
Rate of patients with loss of > 5% body weight
[Time Frame: up to 6 months]
|
Secondary Outcome(s)
|
Assessing the survival rate by phone-calls follow-up every 6 months, up to 2 years
[Time Frame: up to 2 years]
|
Evaluation of Quality of Life of participants (EORTC QLQ-C30 )
[Time Frame: Change from baseline at 12 months]
|
Food intake assessment of participants using SNAQ questionnaire
[Time Frame: Change from baseline at 6 months]
|
Number of participants with pain as main symptom and antialgic therapy
[Time Frame: up to 12 Months]
|
Secondary ID(s)
|
PCD 769/36
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|